We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/5/2021 13:36 | Middle of July is pencilled in Needed to see if the RTO happens or was derisory It turns out it was the second | scottdavid70 | |
31/5/2021 13:25 | When's the book out Scott? | small crow | |
31/5/2021 12:56 | The fact that is inescapable from the Directors point of view and the FCA is that the Director’s have come out FAR BETTER THAN THR SHAREHOLDERS THIS IS THEREFORE NOT IN SHAREHOLDERS BEST INTERESTS take away all the other utter BS Graham Lumsden- Bruce Williams and Jonathan Gold have word vomited up and the fact is they have not done their jobs as designated by law Outlining in a RNS “reasonable consolidation” and then dropping an atomic nuclear device all over shareholders holdings is not looking after shareholders BEST INTERESTS. It was completely disingenuous and they knew it was as do the FCA now along with a lot of the other things that have transpired these past 2 and a half years. None of these Director’s should be allowed to work again and I am very committed to make that scenario a reality now | scottdavid70 | |
31/5/2021 11:29 | It’s just &@£&@&g obscene that they can reward themselves so handsomely after apocalyptic failure. Zero morals but this RTO is a clear breach of being in shareholders best interests. Not one thing that has happened has been in shareholders best interests since 2019. There will be consequences for all of them with regard their reputations and future employment if this deal isn’t re-worked to be in the shareholders best interests. I believe we have enough No votes now to at least stop Gold and Lumsden enriching themselves like uranium any further | scottdavid70 | |
30/5/2021 13:06 | Anyone asked the company what unreasonable consolidation looked like if this was ‘reasonable Shudder to think... | scottdavid70 | |
29/5/2021 22:34 | Its 100% post consolidation. People have already checked. Gold also gets loads more warrants than all existing shareholders combined and he can exercise a lot of them straight away by the looks of things. DYOR. | furryguy | |
29/5/2021 21:41 | Hey if it's post What the hell vote it down if it's pre I'm in clarification in my view is required | tnt99 | |
29/5/2021 15:26 | I think existing shareholders should vote as they see fit. But in doing so they need to be clear there is no chance of an improved or different deal. The value to any RTO target is time to market and that is it. An IPO on AIM is @ a 6 month process and @ GBP 350k. Nobody will pay you more than some faction of that price + any net cash in MTFB. | 40 fathoms | |
29/5/2021 08:57 | Yup I have 15 million and my family and friends another 30 million between the 8 of them. No question we can vote this down and although I stated I would vote through the deal now I have had time to reflect on the deal - nothing is better than this something. It’s a travesty of injustice. A conspiracy of corruption. Motif Bio. Jonathan Gold Graham Lumsden Iclaprim SP Angel Walbrook You can take my money but not my principals There has not been one thing done here where the Director’s have acted in the shareholders best interests which is what their jobs essentially are. On that charge they are all guilty | scottdavid70 | |
29/5/2021 07:42 | I am disgusted by the offer. Waiting almost a year and offered less than 4%?!! One guy with over £3K in shares will have £75 wtf! For the chance of them reconsidering it is worth voting NO. They will not want to do fold the deal .. not with the goodies for JG etc. Highly likely imo they will sweeten the deal for us if we vote no. Or they might not but for the pittance we are being offered it is hardly a difficult decision to make imo. DYOR. | furryguy | |
28/5/2021 23:06 | Tnt99, It's post I'm afraid. | small crow | |
28/5/2021 21:18 | It reads to me pre consolidation 1 warrant for every 2 motif bio shares | tnt99 | |
28/5/2021 19:27 | So are these warrants before or after consolidation makes a big difference | tnt99 | |
28/5/2021 19:04 | It appears to be the case crafty directors just sold the losses they racked up and kept the jewel for themselves wouldn't be surprised if trials are still going on under the orange avenue banner!!! | tnt99 | |
28/5/2021 12:57 | Friend of mine is into the papers and there should be something in the papers the Monday before the vote on all of these white middle aged men who think they can run off with our money without consequences for their future careers | scottdavid70 | |
28/5/2021 12:56 | Nobody knows a thing about Orange Avenue Technologies LLC and who sits on the Board - where it’s incorporated- I have asked several of my friends to make sure this question and many about who stands to benefit via Orange Avenue Technologies LLC and if it’s Motif Bio formers Director’s. No answer naturally but if we all ask maybe they will have to own up to the truth at some point The whole RNS around motif bioscience sake was opaque at best. Tile for the truth to come out. If Iclaprim has value and we don’t get to see any of it then this was deliberately carved out of the RTO to worsen the deal for long term shareholders | scottdavid70 | |
28/5/2021 12:52 | Now we have had the warrants issue cleared up by the muppets at Walbrook even though we all knew what it was if you can read numbers Mate they can confirm if Orange Avenue Technologies LLC gets 10% commission on any sale of Iclaprim or 90% after $250,000 If it’s 90% then it’s time to call the fraud squad in for real | scottdavid70 | |
28/5/2021 12:49 | Amazing that Iclaprim has no inherent value. Strange given Graham Lumsden was so adamant that no matter what they had a clear pathway through one well designed phase iii trial.. yet it has no value in this deal for the very shareholders that invested in its promise. Has Graham Lumsden ever spoken the truth? Yet still received equity for this calamity of a RTO - the man shouldn’t be in charge of a toilet let alone a biotech company | scottdavid70 | |
28/5/2021 11:55 | Yes, he's clearly a bit dense but it's worth pointing put that it seems to be the PR staffer who has apologised - and clearly should resign for getting it so wrong when it was clear from the numbers that is was post-consolidation. Probably an Eng Lit graduate from a private school and St Andrews. | small crow |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions